Korea Investment Corp
NKTR icon

Korea Investment Corp’s Nektar Therapeutics NKTR Stock Holding History

Korea Investment Corp’s Portfolio NKTR Stock Details NKTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-10,380
Closed -$5.23M – 680
2019
Q1 		$5.23M Buy
10,380
+10,247
+7,705% +$6.07M 0.02% 453
2018
Q4 		$65K Sell
133
-7,052
-98% -$4.26M ﹤0.01% 658
2018
Q3 		$6.57M Buy
7,185
+4,639
+182% +$3.96M 0.03% 406
2018
Q2 		$1.86M Buy
+2,546
New +$2.94M 0.01% 613

Other funds holding NKTR

Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Korea Investment Corp's NKTR Position: Q2 2019 in Review

Korea Investment Corp sold out of Nektar Therapeutics (NKTR) in Q2 2019, closing a stake of 10,380 shares — an estimated $5.23M sold.

Korea Investment Corp first reported a position in NKTR in Q2 2018 and held it in 4 quarters. The position peaked at $6.57M in Q3 2018. 336 funds tracked by Wall St. Rank hold NKTR as of Q2 2019.

  • Korea Investment Corp reported no remaining Nektar Therapeutics position as of Q2 2019 after selling out during the quarter.
  • Korea Investment Corp sold 10,380 Nektar Therapeutics shares in Q2 2019, an estimated $5.23M.
  • Korea Investment Corp first reported a position in Nektar Therapeutics in Q2 2018 and held it in 4 quarters.
  • Korea Investment Corp's Nektar Therapeutics position peaked at $6.57M in Q3 2018.
  • 336 funds tracked by Wall St. Rank held Nektar Therapeutics as of Q2 2019.

Based on Korea Investment Corp's 13F filing for Q2 2019, filed 12 Aug 2019.